MLV & Co. Upgrades Cytokinetics (CYTK) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to MLV & Co. Upgrades Cytokinetics (CYTK) to Buy

Cytokinetics (CYTK) Posts Narrower than Expected Q3 Loss

October 31, 2014 9:08 AM EDT

Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($0.16), $0.07 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $7.43 million.

"In the third quarter, Cytokinetics made considerable progress across our development stage programs as we elaborated in our... More